nodes	percent_of_prediction	percent_of_DWPC	metapath
Naloxone—ALB—membranous glomerulonephritis	0.855	1	CbGaD
Naloxone—CREB1—nephron tubule—membranous glomerulonephritis	0.00554	0.151	CbGeAlD
Naloxone—CREB1—epithelium—membranous glomerulonephritis	0.00543	0.148	CbGeAlD
Naloxone—CREB1—kidney—membranous glomerulonephritis	0.00487	0.133	CbGeAlD
Naloxone—CREB1—cortex of kidney—membranous glomerulonephritis	0.00475	0.13	CbGeAlD
Naloxone—OPRD1—kidney—membranous glomerulonephritis	0.00385	0.105	CbGeAlD
Naloxone—SLCO1A2—kidney—membranous glomerulonephritis	0.00226	0.0618	CbGeAlD
Naloxone—ESR1—epithelium—membranous glomerulonephritis	0.00214	0.0584	CbGeAlD
Naloxone—ESR1—kidney—membranous glomerulonephritis	0.00192	0.0524	CbGeAlD
Naloxone—CYP2C8—kidney—membranous glomerulonephritis	0.00158	0.0431	CbGeAlD
Naloxone—CYP3A4—kidney—membranous glomerulonephritis	0.00107	0.0292	CbGeAlD
Naloxone—TLR4—Toll-like Receptor Signaling Pathway—IL1B—membranous glomerulonephritis	0.00106	0.00978	CbGpPWpGaD
Naloxone—ALB—HDL-mediated lipid transport—APOA1—membranous glomerulonephritis	0.00105	0.00971	CbGpPWpGaD
Naloxone—CREB1—Signaling events regulated by Ret tyrosine kinase—RHOA—membranous glomerulonephritis	0.000949	0.00875	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—IL1B—membranous glomerulonephritis	0.000945	0.00871	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—LRP2—membranous glomerulonephritis	0.000944	0.0087	CbGpPWpGaD
Naloxone—CYP2C8—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000936	0.00862	CbGpPWpGaD
Naloxone—ALB—Lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.00093	0.00857	CbGpPWpGaD
Naloxone—CREB1—B Cell Receptor Signaling Pathway—CD79A—membranous glomerulonephritis	0.000902	0.00831	CbGpPWpGaD
Naloxone—CREB1—FOXA2 and FOXA3 transcription factor networks—ALB—membranous glomerulonephritis	0.000892	0.00822	CbGpPWpGaD
Naloxone—TLR4—Spinal Cord Injury—MMP9—membranous glomerulonephritis	0.000891	0.00821	CbGpPWpGaD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SPARC—membranous glomerulonephritis	0.000889	0.00819	CbGpPWpGaD
Naloxone—TLR4—Immune System—C7—membranous glomerulonephritis	0.00087	0.00802	CbGpPWpGaD
Naloxone—ABCB1—nephron tubule—membranous glomerulonephritis	0.000862	0.0235	CbGeAlD
Naloxone—SLCO1A2—Bile acid and bile salt metabolism—ALB—membranous glomerulonephritis	0.000848	0.00781	CbGpPWpGaD
Naloxone—ABCB1—epithelium—membranous glomerulonephritis	0.000845	0.0231	CbGeAlD
Naloxone—TLR4—Regulation of toll-like receptor signaling pathway—IL1B—membranous glomerulonephritis	0.000829	0.00764	CbGpPWpGaD
Naloxone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—membranous glomerulonephritis	0.000812	0.00748	CbGpPWpGaD
Naloxone—OPRM1—IL4-mediated signaling events—CD40LG—membranous glomerulonephritis	0.000777	0.00716	CbGpPWpGaD
Naloxone—CYP2C8—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000759	0.00699	CbGpPWpGaD
Naloxone—ABCB1—kidney—membranous glomerulonephritis	0.000758	0.0207	CbGeAlD
Naloxone—ABCB1—cortex of kidney—membranous glomerulonephritis	0.000738	0.0201	CbGeAlD
Naloxone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000737	0.0068	CbGpPWpGaD
Naloxone—TLR4—Immune System—CFH—membranous glomerulonephritis	0.00069	0.00636	CbGpPWpGaD
Naloxone—ALB—Lipid and lipoprotein metabolism—ABCA1—membranous glomerulonephritis	0.000618	0.0057	CbGpPWpGaD
Naloxone—ALB—Lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000612	0.00564	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—ABCA1—membranous glomerulonephritis	0.000609	0.00561	CbGpPWpGaD
Naloxone—ALB—Lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000605	0.00557	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—RHOA—membranous glomerulonephritis	0.000597	0.00551	CbGpPWpGaD
Naloxone—ESR1—Validated nuclear estrogen receptor alpha network—C3—membranous glomerulonephritis	0.000594	0.00547	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—PLG—membranous glomerulonephritis	0.000566	0.00521	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—RHOA—membranous glomerulonephritis	0.000563	0.00519	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—C7—membranous glomerulonephritis	0.000522	0.00481	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—SPARC—membranous glomerulonephritis	0.000521	0.0048	CbGpPWpGaD
Naloxone—CREB1—Signaling by PDGF—PLG—membranous glomerulonephritis	0.000517	0.00476	CbGpPWpGaD
Naloxone—CREB1—B Cell Activation—CD79A—membranous glomerulonephritis	0.000516	0.00476	CbGpPWpGaD
Naloxone—CYP3A4—Cytochrome P450 - arranged by substrate type—TBXAS1—membranous glomerulonephritis	0.000502	0.00463	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—SPARC—membranous glomerulonephritis	0.000496	0.00457	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—ABCA1—membranous glomerulonephritis	0.000495	0.00456	CbGpPWpGaD
Naloxone—CREB1—Androgen receptor signaling pathway—RHOA—membranous glomerulonephritis	0.000491	0.00452	CbGpPWpGaD
Naloxone—CREB1—Corticotropin-releasing hormone—RHOA—membranous glomerulonephritis	0.000478	0.0044	CbGpPWpGaD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—membranous glomerulonephritis	0.000477	0.00439	CbGpPWpGaD
Naloxone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—membranous glomerulonephritis	0.000474	0.00437	CbGpPWpGaD
Naloxone—CREB1—Leptin signaling pathway—IL1B—membranous glomerulonephritis	0.000474	0.00437	CbGpPWpGaD
Naloxone—CREB1—AP-1 transcription factor network—MMP9—membranous glomerulonephritis	0.000472	0.00435	CbGpPWpGaD
Naloxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOA1—membranous glomerulonephritis	0.000471	0.00434	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—PLG—membranous glomerulonephritis	0.00046	0.00424	CbGpPWpGaD
Naloxone—ABCB1—ABC-family proteins mediated transport—APOA1—membranous glomerulonephritis	0.000458	0.00422	CbGpPWpGaD
Naloxone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—membranous glomerulonephritis	0.000454	0.00419	CbGpPWpGaD
Naloxone—TLR4—Innate Immune System—C3—membranous glomerulonephritis	0.000447	0.00412	CbGpPWpGaD
Naloxone—ALB—FOXA2 and FOXA3 transcription factor networks—APOA1—membranous glomerulonephritis	0.000445	0.0041	CbGpPWpGaD
Naloxone—CREB1—PI3K/AKT activation—RHOA—membranous glomerulonephritis	0.000443	0.00409	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—CFH—membranous glomerulonephritis	0.000414	0.00381	CbGpPWpGaD
Naloxone—CREB1—TCR Signaling Pathway—IL1B—membranous glomerulonephritis	0.00041	0.00377	CbGpPWpGaD
Naloxone—CYP3A4—Phase 1 - Functionalization of compounds—TBXAS1—membranous glomerulonephritis	0.000407	0.00375	CbGpPWpGaD
Naloxone—ALB—Lipid and lipoprotein metabolism—APOE—membranous glomerulonephritis	0.000407	0.00375	CbGpPWpGaD
Naloxone—CYP2C8—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000403	0.00371	CbGpPWpGaD
Naloxone—ALB—Lipid and lipoprotein metabolism—APOA1—membranous glomerulonephritis	0.000402	0.0037	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—APOE—membranous glomerulonephritis	0.0004	0.00369	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—APOA1—membranous glomerulonephritis	0.000396	0.00365	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—PLG—membranous glomerulonephritis	0.000395	0.00364	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—ABCA1—membranous glomerulonephritis	0.000393	0.00362	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CD40—membranous glomerulonephritis	0.000392	0.00361	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD40—membranous glomerulonephritis	0.000384	0.00354	CbGpPWpGaD
Naloxone—OPRD1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.000378	0.00349	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—PLG—membranous glomerulonephritis	0.000376	0.00346	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—RHOA—membranous glomerulonephritis	0.000369	0.0034	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—PLG—membranous glomerulonephritis	0.000366	0.00337	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000364	0.00335	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000363	0.00334	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD79A—membranous glomerulonephritis	0.000361	0.00333	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DQA1—membranous glomerulonephritis	0.00034	0.00313	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000334	0.00307	CbGpPWpGaD
Naloxone—OPRK1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.000332	0.00306	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—APOA1—membranous glomerulonephritis	0.000322	0.00297	CbGpPWpGaD
Naloxone—OPRD1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.000319	0.00294	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000318	0.00293	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000315	0.0029	CbGpPWpGaD
Naloxone—ESR1—Leptin signaling pathway—IL1B—membranous glomerulonephritis	0.00031	0.00286	CbGpPWpGaD
Naloxone—ESR1—AP-1 transcription factor network—MMP9—membranous glomerulonephritis	0.000309	0.00285	CbGpPWpGaD
Naloxone—CREB1—Immune System—C7—membranous glomerulonephritis	0.000304	0.0028	CbGpPWpGaD
Naloxone—OPRM1—TCR Signaling Pathway—IL1B—membranous glomerulonephritis	0.000303	0.00279	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—CD40LG—membranous glomerulonephritis	0.0003	0.00277	CbGpPWpGaD
Naloxone—TLR4—Immune System—CD40LG—membranous glomerulonephritis	0.000295	0.00272	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000281	0.00259	CbGpPWpGaD
Naloxone—OPRM1—Peptide ligand-binding receptors—C3—membranous glomerulonephritis	0.00028	0.00258	CbGpPWpGaD
Naloxone—OPRK1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.00028	0.00258	CbGpPWpGaD
Naloxone—ALB—Platelet degranulation—APOA1—membranous glomerulonephritis	0.000276	0.00254	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.00027	0.00249	CbGpPWpGaD
Naloxone—CREB1—Signaling by SCF-KIT—MMP9—membranous glomerulonephritis	0.00027	0.00248	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000269	0.00248	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—C3—membranous glomerulonephritis	0.000265	0.00245	CbGpPWpGaD
Naloxone—CREB1—Myometrial Relaxation and Contraction Pathways—IL1B—membranous glomerulonephritis	0.000265	0.00244	CbGpPWpGaD
Naloxone—CREB1—SIDS Susceptibility Pathways—IL1B—membranous glomerulonephritis	0.000264	0.00243	CbGpPWpGaD
Naloxone—ALB—Response to elevated platelet cytosolic Ca2+—APOA1—membranous glomerulonephritis	0.000263	0.00242	CbGpPWpGaD
Naloxone—TLR4—Immune System—C3—membranous glomerulonephritis	0.00026	0.0024	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—APOA1—membranous glomerulonephritis	0.000256	0.00236	CbGpPWpGaD
Naloxone—ALB—Vitamin B12 Metabolism—IL1B—membranous glomerulonephritis	0.000255	0.00235	CbGpPWpGaD
Naloxone—OPRD1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.000254	0.00234	CbGpPWpGaD
Naloxone—CREB1—NGF signalling via TRKA from the plasma membrane—RHOA—membranous glomerulonephritis	0.000251	0.00231	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—HLA-DRB1—membranous glomerulonephritis	0.000242	0.00223	CbGpPWpGaD
Naloxone—CREB1—Immune System—CFH—membranous glomerulonephritis	0.000241	0.00222	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PTPRU—membranous glomerulonephritis	0.000238	0.0022	CbGpPWpGaD
Naloxone—TLR4—Immune System—HLA-DRB1—membranous glomerulonephritis	0.000237	0.00219	CbGpPWpGaD
Naloxone—OPRM1—G alpha (i) signalling events—C3—membranous glomerulonephritis	0.000237	0.00218	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—SPARC—membranous glomerulonephritis	0.000231	0.00213	CbGpPWpGaD
Naloxone—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.000223	0.00205	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD40—membranous glomerulonephritis	0.000221	0.00204	CbGpPWpGaD
Naloxone—CYP3A4—Biological oxidations—TBXAS1—membranous glomerulonephritis	0.000216	0.00199	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD79A—membranous glomerulonephritis	0.000208	0.00192	CbGpPWpGaD
Naloxone—ALB—Folate Metabolism—IL1B—membranous glomerulonephritis	0.000208	0.00191	CbGpPWpGaD
Naloxone—OPRD1—GPCR ligand binding—C3—membranous glomerulonephritis	0.000193	0.00178	CbGpPWpGaD
Naloxone—CREB1—Signaling by NGF—RHOA—membranous glomerulonephritis	0.000193	0.00178	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DQA1—membranous glomerulonephritis	0.000192	0.00177	CbGpPWpGaD
Naloxone—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—membranous glomerulonephritis	0.000188	0.00173	CbGpPWpGaD
Naloxone—CREB1—Disease—LRP2—membranous glomerulonephritis	0.000184	0.0017	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	0.000181	0.00167	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—PLG—membranous glomerulonephritis	0.000175	0.00161	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—RHOA—membranous glomerulonephritis	0.000175	0.00161	CbGpPWpGaD
Naloxone—SLCO1A2—SLC-mediated transmembrane transport—ALB—membranous glomerulonephritis	0.000174	0.00161	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—CD40LG—membranous glomerulonephritis	0.00017	0.00156	CbGpPWpGaD
Naloxone—OPRK1—GPCR ligand binding—C3—membranous glomerulonephritis	0.000169	0.00156	CbGpPWpGaD
Naloxone—ALB—Selenium Micronutrient Network—IL1B—membranous glomerulonephritis	0.000165	0.00152	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	0.00016	0.00147	CbGpPWpGaD
Naloxone—ABCB1—Allograft Rejection—IL1B—membranous glomerulonephritis	0.000158	0.00145	CbGpPWpGaD
Naloxone—CREB1—Innate Immune System—C3—membranous glomerulonephritis	0.000156	0.00144	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000155	0.00143	CbGpPWpGaD
Naloxone—TLR4—Immune System—IL1B—membranous glomerulonephritis	0.000155	0.00142	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—TBXAS1—membranous glomerulonephritis	0.000154	0.00142	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—C3—membranous glomerulonephritis	0.00015	0.00138	CbGpPWpGaD
Naloxone—OPRM1—GPCR ligand binding—C3—membranous glomerulonephritis	0.000143	0.00132	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—TBXAS1—membranous glomerulonephritis	0.00014	0.00129	CbGpPWpGaD
Naloxone—CREB1—Axon guidance—MMP9—membranous glomerulonephritis	0.000139	0.00128	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000138	0.00127	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—LRP2—membranous glomerulonephritis	0.000137	0.00126	CbGpPWpGaD
Naloxone—CREB1—Adaptive Immune System—HLA-DRB1—membranous glomerulonephritis	0.000137	0.00126	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD40—membranous glomerulonephritis	0.000134	0.00124	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000133	0.00122	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—membranous glomerulonephritis	0.000132	0.00122	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000129	0.00119	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000129	0.00119	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD79A—membranous glomerulonephritis	0.000126	0.00116	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—LRP2—membranous glomerulonephritis	0.000125	0.00115	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—RHOA—membranous glomerulonephritis	0.000125	0.00115	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—APOA1—membranous glomerulonephritis	0.000122	0.00113	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—PLA2G1B—membranous glomerulonephritis	0.00012	0.00111	CbGpPWpGaD
Naloxone—ALB—Hemostasis—SPARC—membranous glomerulonephritis	0.000119	0.0011	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	0.000119	0.0011	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	0.000118	0.00108	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DQA1—membranous glomerulonephritis	0.000116	0.00107	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—LRP2—membranous glomerulonephritis	0.000113	0.00104	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	0.000112	0.00103	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—C3—membranous glomerulonephritis	0.000109	0.00101	CbGpPWpGaD
Naloxone—CREB1—Immune System—CD40LG—membranous glomerulonephritis	0.000103	0.000948	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—C3—membranous glomerulonephritis	9.95e-05	0.000917	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—C3—membranous glomerulonephritis	9.92e-05	0.000914	CbGpPWpGaD
Naloxone—CREB1—Developmental Biology—MMP9—membranous glomerulonephritis	9.89e-05	0.000911	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—C3—membranous glomerulonephritis	9.58e-05	0.000883	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—LRP2—membranous glomerulonephritis	9.54e-05	0.000879	CbGpPWpGaD
Naloxone—ALB—Platelet activation, signaling and aggregation—RHOA—membranous glomerulonephritis	9.37e-05	0.000864	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	9.32e-05	0.000859	CbGpPWpGaD
Naloxone—CREB1—Immune System—C3—membranous glomerulonephritis	9.09e-05	0.000838	CbGpPWpGaD
Naloxone—ALB—Hemostasis—PLG—membranous glomerulonephritis	9.02e-05	0.000832	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	8.89e-05	0.000819	CbGpPWpGaD
Naloxone—SLCO1A2—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	8.86e-05	0.000816	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—ABCA1—membranous glomerulonephritis	8.84e-05	0.000814	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—C3—membranous glomerulonephritis	8.7e-05	0.000801	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—LRP2—membranous glomerulonephritis	8.46e-05	0.000779	CbGpPWpGaD
Naloxone—CREB1—Immune System—HLA-DRB1—membranous glomerulonephritis	8.28e-05	0.000763	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—C3—membranous glomerulonephritis	8.09e-05	0.000746	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ABCA1—membranous glomerulonephritis	8.05e-05	0.000742	CbGpPWpGaD
Naloxone—CREB1—Disease—APOE—membranous glomerulonephritis	7.81e-05	0.00072	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	7.81e-05	0.00072	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—PLG—membranous glomerulonephritis	7.73e-05	0.000713	CbGpPWpGaD
Naloxone—CREB1—Disease—APOA1—membranous glomerulonephritis	7.72e-05	0.000712	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—PLG—membranous glomerulonephritis	7.71e-05	0.00071	CbGpPWpGaD
Naloxone—OPRD1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	7.7e-05	0.000709	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—C3—membranous glomerulonephritis	7.35e-05	0.000677	CbGpPWpGaD
Naloxone—CREB1—Signaling by GPCR—RHOA—membranous glomerulonephritis	7.01e-05	0.000646	CbGpPWpGaD
Naloxone—OPRD1—Signaling by GPCR—RHOA—membranous glomerulonephritis	6.99e-05	0.000644	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—TBXAS1—membranous glomerulonephritis	6.89e-05	0.000635	CbGpPWpGaD
Naloxone—ALB—Metabolism—TBXAS1—membranous glomerulonephritis	6.85e-05	0.000631	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—PLG—membranous glomerulonephritis	6.84e-05	0.000631	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—PLG—membranous glomerulonephritis	6.76e-05	0.000623	CbGpPWpGaD
Naloxone—OPRK1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	6.75e-05	0.000622	CbGpPWpGaD
Naloxone—ALB—Hemostasis—APOA1—membranous glomerulonephritis	6.31e-05	0.000582	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—LRP2—membranous glomerulonephritis	6.14e-05	0.000566	CbGpPWpGaD
Naloxone—OPRK1—Signaling by GPCR—RHOA—membranous glomerulonephritis	6.13e-05	0.000565	CbGpPWpGaD
Naloxone—ALB—Metabolism—LRP2—membranous glomerulonephritis	6.11e-05	0.000563	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—TBXAS1—membranous glomerulonephritis	6e-05	0.000553	CbGpPWpGaD
Naloxone—CREB1—Disease—RHOA—membranous glomerulonephritis	5.91e-05	0.000545	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—PLA2G1B—membranous glomerulonephritis	5.91e-05	0.000545	CbGpPWpGaD
Naloxone—ALB—Metabolism—PLA2G1B—membranous glomerulonephritis	5.88e-05	0.000542	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—C3—membranous glomerulonephritis	5.88e-05	0.000542	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—C3—membranous glomerulonephritis	5.86e-05	0.00054	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.84e-05	0.000539	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—APOE—membranous glomerulonephritis	5.81e-05	0.000536	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.78e-05	0.000533	CbGpPWpGaD
Naloxone—ALB—Metabolism of lipids and lipoproteins—APOA1—membranous glomerulonephritis	5.75e-05	0.000529	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—PLG—membranous glomerulonephritis	5.71e-05	0.000527	CbGpPWpGaD
Naloxone—OPRM1—GPCR downstream signaling—RHOA—membranous glomerulonephritis	5.7e-05	0.000526	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOE—membranous glomerulonephritis	5.47e-05	0.000504	CbGpPWpGaD
Naloxone—ALB—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	5.46e-05	0.000503	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOE—membranous glomerulonephritis	5.45e-05	0.000503	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—APOA1—membranous glomerulonephritis	5.41e-05	0.000498	CbGpPWpGaD
Naloxone—CREB1—Immune System—IL1B—membranous glomerulonephritis	5.4e-05	0.000497	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—APOA1—membranous glomerulonephritis	5.39e-05	0.000497	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—LRP2—membranous glomerulonephritis	5.35e-05	0.000493	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOE—membranous glomerulonephritis	5.3e-05	0.000488	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—APOA1—membranous glomerulonephritis	5.24e-05	0.000483	CbGpPWpGaD
Naloxone—OPRM1—Signaling by GPCR—RHOA—membranous glomerulonephritis	5.18e-05	0.000477	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—PLA2G1B—membranous glomerulonephritis	5.15e-05	0.000475	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—C3—membranous glomerulonephritis	5.14e-05	0.000473	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—PLG—membranous glomerulonephritis	5.07e-05	0.000467	CbGpPWpGaD
Naloxone—ALB—Hemostasis—RHOA—membranous glomerulonephritis	4.83e-05	0.000445	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—APOA1—membranous glomerulonephritis	4.79e-05	0.000441	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOE—membranous glomerulonephritis	4.78e-05	0.000441	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—APOA1—membranous glomerulonephritis	4.73e-05	0.000436	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—membranous glomerulonephritis	4.58e-05	0.000422	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—C3—membranous glomerulonephritis	4.34e-05	0.0004	CbGpPWpGaD
Naloxone—SLCO1A2—Metabolism—ALB—membranous glomerulonephritis	4.15e-05	0.000382	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—RHOA—membranous glomerulonephritis	4.14e-05	0.000382	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—RHOA—membranous glomerulonephritis	4.13e-05	0.000381	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOE—membranous glomerulonephritis	4.04e-05	0.000373	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—APOA1—membranous glomerulonephritis	4e-05	0.000368	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ABCA1—membranous glomerulonephritis	3.96e-05	0.000365	CbGpPWpGaD
Naloxone—ALB—Metabolism—ABCA1—membranous glomerulonephritis	3.93e-05	0.000363	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—C3—membranous glomerulonephritis	3.85e-05	0.000355	CbGpPWpGaD
Naloxone—ABCB1—Transmembrane transport of small molecules—ALB—membranous glomerulonephritis	3.79e-05	0.000349	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—TBXAS1—membranous glomerulonephritis	3.7e-05	0.000341	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.62e-05	0.000334	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOE—membranous glomerulonephritis	3.58e-05	0.00033	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—APOA1—membranous glomerulonephritis	3.54e-05	0.000327	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ABCA1—membranous glomerulonephritis	3.45e-05	0.000318	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—LRP2—membranous glomerulonephritis	3.3e-05	0.000304	CbGpPWpGaD
Naloxone—CREB1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.29e-05	0.000303	CbGpPWpGaD
Naloxone—OPRD1—Signaling Pathways—MMP9—membranous glomerulonephritis	3.28e-05	0.000302	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—PLA2G1B—membranous glomerulonephritis	3.17e-05	0.000292	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—RHOA—membranous glomerulonephritis	3.06e-05	0.000282	CbGpPWpGaD
Naloxone—OPRK1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.87e-05	0.000265	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—RHOA—membranous glomerulonephritis	2.71e-05	0.00025	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOE—membranous glomerulonephritis	2.6e-05	0.00024	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOE—membranous glomerulonephritis	2.59e-05	0.000239	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—APOA1—membranous glomerulonephritis	2.57e-05	0.000237	CbGpPWpGaD
Naloxone—ALB—Metabolism—APOA1—membranous glomerulonephritis	2.56e-05	0.000236	CbGpPWpGaD
Naloxone—OPRM1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.43e-05	0.000224	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOE—membranous glomerulonephritis	2.27e-05	0.000209	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—APOA1—membranous glomerulonephritis	2.24e-05	0.000207	CbGpPWpGaD
Naloxone—ESR1—Signaling Pathways—MMP9—membranous glomerulonephritis	2.15e-05	0.000199	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ABCA1—membranous glomerulonephritis	2.12e-05	0.000196	CbGpPWpGaD
Naloxone—CYP2C8—Metabolism—ALB—membranous glomerulonephritis	2.04e-05	0.000188	CbGpPWpGaD
Naloxone—ABCB1—Metabolism—ALB—membranous glomerulonephritis	1.78e-05	0.000164	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOE—membranous glomerulonephritis	1.4e-05	0.000129	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—APOA1—membranous glomerulonephritis	1.38e-05	0.000127	CbGpPWpGaD
Naloxone—CYP3A4—Metabolism—ALB—membranous glomerulonephritis	1.09e-05	0.000101	CbGpPWpGaD
